A Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 10 May 2017
At a glance
- Drugs Insulin degludec/liraglutide (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms DUAL VIII
- Sponsors Novo Nordisk
- 07 Jun 2017 Biomarkers information updated
- 22 Mar 2017 Last checked against European Clinical Trials Database record.
- 03 Mar 2017 Planned End Date changed from 1 Oct 2018 to 3 Oct 2018.